Dr Luis Alameda studied at Universities of Sevilla, Lund and Florence and he trained in psychiatry and psychotherapy in Lausanne University Hospital. From 2017 to 2022 he worked at South London and Maudsley NHS Foundation Trust as a Consultant psychiatrist while completing a PhD in the Department of Psychosis Studies at the Institute of Psychiatry, Psychology & Neuroscience. His PhD was awarded the 2022/23 King's Outstanding Thesis Prize and the Psychosis Studies PhD of the Year award, both in 2022. Dr Alameda has also been awarded the 2019 Research Prize by the European Psychiatric Association for one of his publications. Since April 2022, Dr Alameda has led the Treatment and Early Intervention in Psychosis Program (TIPP) in Lausanne while he keeps collaborating with the IoPPN as a research fellow.

Research Interests

Dr Luis Alameda’s research is on the link between childhood trauma and psychosis, from clinical aspects to molecular mechanisms.

Key Publications

• Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
• Can epigenetics shine a light on the biological pathways underlying major mental disorders?
• Association Between Specific Childhood Adversities and Symptom Dimensions in People With Psychosis: Systematic Review and Meta-Analysis
• A systematic review on mediators between adversity and psychosis: potential targets for treatment
• Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis